open access
Cancer incidence and mortality in Poland in 2023
- Polish National Cancer Registry, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
- Department of Epidemiology and Cancer Prevention, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
- Faculty of Biomedical Engineering, Silesian University of Technology, Zabrze, Poland
- Department of Dietetics, Institute of Human Nutrition Sciences, Warsaw University of Life Sciences, Warsaw, Poland
open access
Abstract
Introduction. Cancers are a real global health problem. Europe accounts for 1/10 of the world's population, but ¼ of all cancer cases occurs in this region. Poland is in the group of countries where cancer mortality is the highest [1]. The aim of this article is to present a summary of the epidemiological indicators of malignant neoplasms in Poland in 2023.
Material and methods. This report presents observed morbidity and mortality data for 2010–2021 and also estimated values two years ahead (2022–2023). Data aggregation was carried out according to sex, age, cancer site, or administrative division of Poland. Time trends were determined using joinpoint regression [2]. The Polish National Cancer Registry is responsible for gathering cancer morbidity data in Poland; mortality data came from the Statistics Poland [3].
Results. The Polish National Cancer Registry reported about 171,558 new cases and 93,652 thousand cancer deaths in 2021. The most common cancers in men were prostate, lung, and colon cancer. The most common cancers in women were breast, lung, and colorectal cancers. The prediction of morbidity and mortality for 2023 indicates a continuation of long-term trends.
Conclusions. The increase in the number of cases (approximately 25,000) and the number of deaths (by approximately 6000) observed in 2021 compared to 2020 indicates the huge impact of the COVID-19 pandemic on health indicators in Poland. However, the year 2021 shows the characteristics of the previous trend among cancer data.
Abstract
Introduction. Cancers are a real global health problem. Europe accounts for 1/10 of the world's population, but ¼ of all cancer cases occurs in this region. Poland is in the group of countries where cancer mortality is the highest [1]. The aim of this article is to present a summary of the epidemiological indicators of malignant neoplasms in Poland in 2023.
Material and methods. This report presents observed morbidity and mortality data for 2010–2021 and also estimated values two years ahead (2022–2023). Data aggregation was carried out according to sex, age, cancer site, or administrative division of Poland. Time trends were determined using joinpoint regression [2]. The Polish National Cancer Registry is responsible for gathering cancer morbidity data in Poland; mortality data came from the Statistics Poland [3].
Results. The Polish National Cancer Registry reported about 171,558 new cases and 93,652 thousand cancer deaths in 2021. The most common cancers in men were prostate, lung, and colon cancer. The most common cancers in women were breast, lung, and colorectal cancers. The prediction of morbidity and mortality for 2023 indicates a continuation of long-term trends.
Conclusions. The increase in the number of cases (approximately 25,000) and the number of deaths (by approximately 6000) observed in 2021 compared to 2020 indicates the huge impact of the COVID-19 pandemic on health indicators in Poland. However, the year 2021 shows the characteristics of the previous trend among cancer data.
Keywords
mortality; morbidity; neoplasms; Poland
Title
Cancer incidence and mortality in Poland in 2023
Journal
Nowotwory. Journal of Oncology
Issue
Article type
Research paper (original)
Published online
2024-02-28
Page views
420
Article views/downloads
242
DOI
Keywords
mortality
morbidity
neoplasms
Poland
Authors
Joanna Didkowska
Klaudia Barańska
Marta Julia Miklewska
Urszula Wojciechowska
- Dyba T, Randi G, Bray F, et al. The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer. 2021; 157: 308–347.
- Kim HJ, Fay M, Feuer E, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2001; 19(3): 335–351, doi: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z.
- Statistics Poland. https://stat.gov.pl/en/ (22.01.2024).
- Causes of death statistics. https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Causes_of_death_statistics (22.01.2024).
- Didkowska J, Wojciechowska U, Barańska K. Nowotwory złośliwe w Polsce w 2021 roku [Cancer in Poland in 2021]. Krajowy Rejestr Nowotworów [Polish National Cancer Registry], Warszawa 2023.
- International statistical classification of diseases and related health problems. World Health Organization, 2015. https://iris.who.int/handle/10665/246208 (22.01.2024).
- European Commission, Eurostat. Revision of the European Standard Population: report of Eurostat’s task force: 2013 edition. LU: Publications Office, 2013. https://data.europa.eu/doi/10.2785/11470 (25.10.2022).
- Didkowska J, Wojciechowska U, Olasek P, et al. Nowotwory złośliwe w Polsce w 2019 roku [Cancer in Poland in 2019]. Krajowy Rejestr Nowotworów [Polish National Cancer Registry] 2021. https://onkologia.org.pl/sites/default/files/publications/2022-05/Nowotwory_2019.pdf.